Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2303]
News [5290]
Articles [130]
Editorials [4]
Conferences [158]
elearning [13]
FDA approves new type of therapy to treat advanced urothelial cancer
FDA approves new type of therapy to treat advanced urothelial cancer
FDA approves enzalutamide for metastatic castration-sensitive prostate cancer
FDA approves enzalutamide for metastatic castration-sensitive prostate cancer
Standard of care chemoradiation for stage III NSCLC is superior to two tested alternatives
Standard of care chemoradiation for stage III NSCLC is superior to two tested alternatives
SABCS 2019: Adding tucatinib to drug combination extends survival for advanced HER2-positive breast cancer patients
SABCS 2019: Adding tucatinib to drug combination extends survival for advanced HER2-positive breast cancer patients
SABCS 2019: New HER2 antibody-drug conjugate yielded promising clinical responses in breast cancer patients pretreated with T-DM1
SABCS 2019: New HER2 antibody-drug conjugate yielded promising clinical responses in breast cancer patients...
ASH 2019: Triple drug combination delays disease progression in people with stubborn multiple myeloma
ASH 2019: Triple drug combination delays disease progression in people with stubborn multiple myeloma
Anti-CTLA-4 antibody tremelimumab shows efficacy in patients with metastatic bladder cancer
Anti-CTLA-4 antibody tremelimumab shows efficacy in patients with metastatic bladder cancer
ASH 2019: Dual-targeted antibody elicits durable responses in poor-prognosis non-Hodgkin Lymphoma
ASH 2019: Dual-targeted antibody elicits durable responses in poor-prognosis non-Hodgkin Lymphoma
Recruitment of miR-8080 by luteolin inhibits AR-V7 in castration-resistant prostate cancer
Recruitment of miR-8080 by luteolin inhibits AR-V7 in castration-resistant prostate cancer
Updated NCCN genetic screening guidelines feature emerging evidence on personalised medicine
Updated NCCN genetic screening guidelines feature emerging evidence on personalised medicine

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation